For the readers interested in the stock health of Hepion Pharmaceuticals Inc. (HEPA). It is currently valued at $2.98. When the trading was stopped its value was $2.28.
Recently in News on February 5, 2021, Tiziana Life Sciences plc (“Tiziana” or the “Company”) – Appointment of Director. Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces the appointment of Dr. Thomas Adams, Ph.D. as an executive director. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Hepion Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.98 on 02/08/21, with the lowest value was $2.01 for the same time period, recorded on 01/28/21.
Hepion Pharmaceuticals Inc. (HEPA) full year performance was -39.43%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Hepion Pharmaceuticals Inc. shares are logging -43.24% during the 52-week period from high price, and 198.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.00 and $5.25.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 6324783 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Hepion Pharmaceuticals Inc. (HEPA) recorded performance in the market was 36.07%, having the revenues showcasing 9.56% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 95.81M, as it employees total of 12 workers.
Specialists analysis on Hepion Pharmaceuticals Inc. (HEPA)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.57, with a change in the price was noted -0.27. In a similar fashion, Hepion Pharmaceuticals Inc. posted a movement of -8.31% for the period of last 100 days, recording 1,513,875 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for HEPA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.02.
Trends and Technical analysis: Hepion Pharmaceuticals Inc. (HEPA)
Raw Stochastic average of Hepion Pharmaceuticals Inc. in the period of last 50 days is set at 100.00%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 100.00%. In the last 20 days, the company’s Stochastic %K was 76.98% and its Stochastic %D was recorded 64.87%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 36.07%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -32.12%, alongside a downfall of -39.43% for the period of the last 12 months. The shares increased approximately by 39.91% in the 7-day charts and went down by 43.27% in the period of the last 30 days. Common stock shares were driven by 9.56% during last recorded quarter.